[HTML][HTML] Safety and efficacy of Paxlovid against Omicron variants of coronavirus disease 2019 in elderly patients

C Weng, R Xie, G Han, Y Yuan, S Li, C Wang… - Infectious Diseases and …, 2023 - Springer
Introduction Elderly patients are the most affected and vulnerable to COVID-19 and effective
therapeutic interventions are urgently required. We clarified the safety and efficacy of …

[HTML][HTML] Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients

C Weng, R Xie, G Han, Y Yuan, S Li… - Infectious Diseases …, 2023 - ncbi.nlm.nih.gov
Methods Patients aged over 60 years and with mild to moderate COVID-19 were admitted to
the Zhongshan Hospital MinHang MeiLong Branch, Fudan University and received either …

Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients

C Weng, R Xie, G Han, Y Yuan, S Li… - Infectious diseases …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Elderly patients are the most affected and vulnerable to COVID-19 and effective
therapeutic interventions are urgently required. We clarified the safety and efficacy of …

Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients.

C Weng, R Xie, G Han, Y Yuan, S Li… - Infectious Diseases …, 2023 - europepmc.org
Methods Patients aged over 60 years and with mild to moderate COVID-19 were admitted to
the Zhongshan Hospital MinHang MeiLong Branch, Fudan University and received either …

Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients

C Weng, R Xie, G Han, Y Yuan, S Li… - Infectious Diseases …, 2023 - search.proquest.com
Methods Patients aged over 60 years and with mild to moderate COVID-19 were admitted to
the Zhongshan Hospital MinHang MeiLong Branch, Fudan University and received either …

[PDF][PDF] Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients

CWRXG Han, Y Yuan, SLCWX Wang, W Jiang - therapy, 2023 - scienceopen.com
Introduction: Elderly patients are the most affected and vulnerable to COVID-19 and effective
therapeutic interventions are urgently required. We clarified the safety and efficacy of …

Safety and efficacy of Paxlovid against omicron variants of Coronavirus disease 2019 in elderly patients.

C Weng, R Xie, G Han, Y Yuan, S Li, C Wang, X Wang… - 2023 - cabidigitallibrary.org
Introduction: Elderly patients are the most affected and vulnerable to COVID-19 and effective
therapeutic interventions are urgently required. We clarified the safety and efficacy of …

Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients.

C Weng, R Xie, G Han, Y Yuan, S Li… - … Diseases & Therapy, 2023 - search.ebscohost.com
Introduction: Elderly patients are the most affected and vulnerable to COVID-19 and effective
therapeutic interventions are urgently required. We clarified the safety and efficacy of …

Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients.

C Weng, R Xie, G Han, Y Yuan, S Li, C Wang… - Infectious Diseases and …, 2023 - go.gale.com
Introduction Elderly patients are the most affected and vulnerable to COVID-19 and effective
therapeutic interventions are urgently required. We clarified the safety and efficacy of …

[引用][C] Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients

CWRXG Han, Y Yuan, SLCWX Wang, W Jiang - therapy, 2023 - europepmc.org
Introduction: Elderly patients are the most affected and vulnerable to COVID-19 and effective
therapeutic interventions are urgently required. We clarified the safety and efficacy of …